Trade AIDX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
20/20 Biolabs, Inc. (AIDX) is trading at US$0.47, down 1.36% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$7.08M. Over the past 52 weeks, AIDX has traded between US$0.40 and US$50.00. On Syfe you can trade AIDX with $0 commission and add it to your watchlist.
| Previous close | US$0.47 |
|---|---|
| Market cap | US$7.08M |
| 52-week range | US$0.40 – US$50.00 |
| Volume | 28.82K |
| Exchange | US |
Add to Watchlist
Set Price Alert
20/20 Biolabs, Inc.
20/20 Biolabs, Inc. engages in development and commercialization of proteomics product line. Its products include One Test, PAULA's Test and BioCheck Suspisious Powder Testing Kit. The company was founded by Jonathan Cohen in May 2000 and is headquartered in Gaithersburg, MD.
Year: 2026
20/20 Biolabs, Inc. (AIDX) stock is trading at US$0.47, -1.36% from the previous close of US$0.47.
The market cap for 20/20 Biolabs, Inc. (AIDX) stock is approximately US$7.08M.
The 52-week high for 20/20 Biolabs, Inc. (AIDX) stock is US$50.00.
The 52-week low for 20/20 Biolabs, Inc. (AIDX) stock is US$0.40.
20/20 Biolabs, Inc. (AIDX) does not currently pay a dividend.
Stay on top of AIDX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
